The Atlanta Journal-Constitution

Drug czar nominee pulls name from considerat­ion, Trump says

Report said Marino helped pass law that hobbled the DEA.

- By Anne Gearan, Lenny Bernstein, Scott Higham and Ed O’Keefe

WASHINGTON — President Donald Trump on Tuesday said his nominee to be the nation’s drug czar is withdrawin­g from considerat­ion for the job — a move that comes in the wake of a Washington Post/“60 Minutes” investigat­ion detailing how the lawmaker helped steer legislatio­n through Congress that weakened the Drug Enforcemen­t Administra­tion’s ability to go after drug distributo­rs, even as opioid-related deaths continue to rise.

On Monday, following the report, Democrats called on Trump to quickly discard Rep. Tom Marino, R-Pa., who was nominated in September to lead the Office of National Drug Control Policy.

“Rep. Tom Marino has informed me that he is withdrawin­g his name from considerat­ion as drug czar,” Trump said in a Tuesday morning tweet. “Tom is a fine man and a great Congressma­n!”

Trump declined to express support for Marino on Monday when asked about his nominee during a news conference, saying, “we’re going to be looking into” the Post/“60 Minutes” report. Many Democrats and at least one Republican have called for modificati­on or outright repeal of the law the investigat­ion showed was the result of a targeted lobbying campaign by the drug distributi­on industry.

The president also said Monday that he will declare a national emergency next week to address the opioid epidemic.

Speaking in the White House Rose Garden, Trump defended Marino as “a very early supporter of mine” and “a great guy.” He said that he had seen the reporting in question and that the White House would review the informatio­n.

Marino, 65, represents Pennsylvan­ia’s 10th Congressio­nal District, a solid-red, mostly rural area that voted overwhelmi­ngly for Trump last year. Marino served as U.S. attorney for the Middle District of Pennsylvan­ia during the Bush administra­tion and previously served as district attorney for Lycoming County, which encompasse­s Williamspo­rt.

Marino hadn’t been making plans for reelection and it wasn’t clear Tuesday whether he would seek a fifth term next year. But congressio­nal Democrats pounced, calling him part of a growing scandalize­d culture among House Republican­s, which includes at least one lawmaker under Justice Department investigat­ion, another facing a growing ethics probe and another who announced his retirement this month as tawdry details of an affair came to light.

“At this point, the whole House stinks and that will make it more difficult for House Republican­s to defend their imperiled majority,” the Democratic Congressio­nal Campaign Committee said in a statement.

Marino first won his seat in 2010 and has won each of his races with at least 55 percent of the vote. He sits on the Judiciary, Homeland Security and Foreign Affairs committees.

Following reports Tuesday of Marino’s withdrawal, Senate Minority Leader Charles Schumer, D-N.Y., called Trump’s announceme­nt “the right decision” but said that the nomination “is further evidence that when it comes to the opioid crisis, the Trump administra­tion talks the talk, but refuses to walk the walk.”

Democratic Sen. Joe Manchin, W.Va., whose state has been hard hit by the opioid epidemic, said he welcomed the news. He was among the first to call for Marino’s nomination to be withdrawn.

“We need a drug czar who has seen these devastatin­g effects and who is passionate about ending this opioid epidemic. I look forward to working with President Trump to find a drug czar that will serve West Virginians and our entire country,” he said in a statement Tuesday.

The chief advocate of the law that hobbled the DEA was Marino, who spent years trying to move it through Congress. It passed after Sen. Orrin Hatch, R-Utah, negotiated a final version with the DEA.

Hatch defended his support of the legislatio­n and Marino on Monday, saying in a statement that he “does not believe one flawed report should derail a nominee who has a long history of fighting illegal drug use and of helping individual­s with chronic conditions obtain treatment.”

“Let’s not ignore the full story here in the rush toward easy politics,” Hatch added.

 ?? SUSAN WALSH / AP 2011 ?? Rep. Thomas Marino, R-Pa., was accused in a Washington Post/“60 Minutes” investigat­ion of playing a key role in passing a bill weakening the Drug Enforcemen­t Administra­tion’s authority to stop companies from giving opioids.
SUSAN WALSH / AP 2011 Rep. Thomas Marino, R-Pa., was accused in a Washington Post/“60 Minutes” investigat­ion of playing a key role in passing a bill weakening the Drug Enforcemen­t Administra­tion’s authority to stop companies from giving opioids.

Newspapers in English

Newspapers from United States